391 related articles for article (PubMed ID: 18325893)
1. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.
Cesaro A; Bettoni RR; Lascols C; Mérens A; Soussy CJ; Cambau E
J Antimicrob Chemother; 2008 May; 61(5):1007-15. PubMed ID: 18325893
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli.
Yue L; Jiang HX; Liao XP; Liu JH; Li SJ; Chen XY; Chen CX; Lü DH; Liu YH
Vet Microbiol; 2008 Dec; 132(3-4):414-20. PubMed ID: 18573620
[TBL] [Abstract][Full Text] [Related]
3. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J; Luo Y; Cui S; Wang W; Han L
Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
[TBL] [Abstract][Full Text] [Related]
4. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
Lascols C; Robert J; Cattoir V; Bébéar C; Cavallo JD; Podglajen I; Ploy MC; Bonnet R; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
[TBL] [Abstract][Full Text] [Related]
5. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
[TBL] [Abstract][Full Text] [Related]
7. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
[TBL] [Abstract][Full Text] [Related]
8. Qnr-like pentapeptide repeat proteins in gram-positive bacteria.
Rodríguez-Martínez JM; Velasco C; Briales A; García I; Conejo MC; Pascual A
J Antimicrob Chemother; 2008 Jun; 61(6):1240-3. PubMed ID: 18343805
[TBL] [Abstract][Full Text] [Related]
9. Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals.
Gibson JS; Cobbold RN; Heisig P; Sidjabat HE; Kyaw-Tanner MT; Trott DJ
Vet Microbiol; 2010 Jul; 143(2-4):329-36. PubMed ID: 20036084
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to quinolones.
Jacoby GA
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S120-6. PubMed ID: 15942878
[TBL] [Abstract][Full Text] [Related]
11. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China.
Jiang Y; Zhou Z; Qian Y; Wei Z; Yu Y; Hu S; Li L
J Antimicrob Chemother; 2008 May; 61(5):1003-6. PubMed ID: 18299311
[TBL] [Abstract][Full Text] [Related]
12. Transferable plasmid-mediated quinolone resistance in association with extended-spectrum β-lactamases and fluoroquinolone-acetylating aminoglycoside-6'-N-acetyltransferase in clinical isolates of Vibrio fluvialis.
Chowdhury G; Pazhani GP; Nair GB; Ghosh A; Ramamurthy T
Int J Antimicrob Agents; 2011 Aug; 38(2):169-73. PubMed ID: 21683552
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of qnr determinants among extended-spectrum beta-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden.
Fang H; Huang H; Shi Y; Hedin G; Nord CE; Ullberg M
Int J Antimicrob Agents; 2009 Sep; 34(3):268-70. PubMed ID: 19409763
[TBL] [Abstract][Full Text] [Related]
14. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of plasmid-mediated quinolone resistance determinants among Escherichia coli strains isolated from animals in Tunisia: Specific pathovars acquired qnr genes.
Kilani H; Ferjani S; Mansouri R; Boutiba-Benboubaker I; Abbassi MS
J Glob Antimicrob Resist; 2020 Mar; 20():50-55. PubMed ID: 31365855
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
Shen JL; Zhu DM; Wang MG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-mediated quinolone resistance conferred by qnrS1 in Salmonella enterica serovar Virchow isolated from Turkish food of avian origin.
Avsaroglu MD; Helmuth R; Junker E; Hertwig S; Schroeter A; Akcelik M; Bozoglu F; Guerra B
J Antimicrob Chemother; 2007 Nov; 60(5):1146-50. PubMed ID: 17881633
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
19. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
Avrain L; Garvey M; Mesaros N; Glupczynski Y; Mingeot-Leclercq MP; Piddock LJ; Tulkens PM; Vanhoof R; Van Bambeke F
J Antimicrob Chemother; 2007 Nov; 60(5):965-72. PubMed ID: 17693451
[TBL] [Abstract][Full Text] [Related]
20. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
Vinué L; Corcoran MA; Hooper DC; Jacoby GA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
